Response-adaptive designs, which aim to reduce the number of patients receiving inferior treatments, are popular in Phase III clinical trials. This book provides an overview of the research in this area.
Extensions of the robust multiple regression model include Bayesian, heteroskedastic, time series and compositional regression, together with the clustering of regression models.